Skip to main content

1 Result(s)

within Article Remove this filter M. E. Elez Remove this filter Hematology Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis

    Cetuximab was approved using a weekly schedule, alone or in combination with chemotherapy (CT). However, many CT regimens in metastatic colorectal cancer (CRC) are delivered every 2 weeks (q2wks). Preliminary ...

    M. Bouchahda, T. Macarulla, G. LIedo, F. Lévi, M. E. Elez, B. Paule… in Medical Oncology (2011)